phase readout
saveNCT07579936: A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
RECRUITINGupdated just now
community read0 votes
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.. Phase: PHASE2. Conditions: Postmenopausal Women With Osteoporosis
view source ↗
comments(0)
5-min edit window · permanent after that